Baseline variable patients with concomitant CABG/AV surgery
| Characteristics | Total CABG/AV cohort (n=5867) n (%) | Male (n=3937, 67%) n (%) | Female (n=1928, 33%) n (%) | P values |
| Age | 72.8±8.2 (31–94) | 71.7±8.2 (31–93) | 75.0±7.5 (33–94) | < 0.001 |
| Chronic lung disease | 894 (15.2) | 660 (16.8) | 234 (12.1) | < 0.001 |
| Extracardiac arteriopathy | 992 (16.9) | 743 (18.9) | 249 (12.9) | < 0.001 |
| Neurological dysfunction | 181 (3.1) | 136 (3.5) | 45 (2.3) | < 0.001 |
| Prior cardiac surgery | 250 (4.3) | 186 (4.7) | 64 (3.3) | < 0.001 |
| Serum creatinine (>200 μm/L) | 132 (2.2) | 105 (2.7) | 27 (1.4) | < 0.001 |
| Active endocarditis | 48 (0.8) | 41 (1.0) | 7 (0.4) | < 0.001 |
| Critical preoperative state | 108 (1.8) | 73 (1.9) | 35 (1.8) | 0.918 |
| Unstable angina | 148 (2.5) | 95 (2.4) | 53 (2.7) | 0.440 |
| LV function | ||||
| Good | 4463 (76.1) | 2878 (73.1) | 1583 (82.1) | |
| Moderate | 1128 (19.2) | 833 (21.2) | 295 (15.3) | < 0.001 |
| Poor | 274 (4.7) | 225 (5.7) | 49 (2.5) | < 0.001 |
| Recent myocardial infarction | 368 (6.3) | 256 (6.5) | 112 (5.8) | 0.305 |
| Pulmonary hypertension | 176 (3.0) | 110 (2.8) | 65 (3.4) | 0.222 |
| Emergent surgery | 121 (2.1) | 77 (2.0) | 44 (2.3) | 0.408 |
| Surgery on thoracic aorta | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| Postinfarct septal rupture | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| Prior PCI | 532 (9.1) | 388 (9.9) | 144 (7.5) | 0.002 |
| Prior CABG | 172 (2.9) | 131 (3.3) | 41 (2.1) | 0.010 |
| Prior valve surgery | 60 (1.0) | 131 (3.3) | 41 (2.1) | 0.447 |
| Prior aorta surgery | 13 (0.2) | 11 (0.3) | 2 (0.1) | 0.178 |
| Prior other cardiac surgery | 137 (2.3) | 106 (2.7) | 31 (1.6) | 0.009 |
Significant values are depicted in bold.
AV, aortic valve; CABG, coronary artery bypass graft; LV, left ventricular; PCI, percutaneous coronary intervention.